SHWZ Quote, Financials, Valuation and Earnings

Ladybug Resource Group has a net margin of -32.23% compared to Medicine Man Technologies's net margin of --. Medicine Man Technologies's return on equity of -39.36% beat Ladybug Resource Group's return on equity of --.

Medicine Man Technologies has a consensus price target of --, signalling upside risk potential of 13101.65%. On the other hand Ladybug Resource Group has an analysts' consensus of -- which suggests that it could fall by --. Given that Medicine Man Technologies has higher upside potential than Ladybug Resource Group, analysts believe Medicine Man Technologies is more attractive than Ladybug Resource Group.

Medicine Man Technologies has a beta of 1.838, which suggesting that the stock is 83.805% more volatile than S&P 500. In comparison Ladybug Resource Group has a beta of -9.829, suggesting its less volatile than the S&P 500 by 1082.903%.

Medicine Man Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ladybug Resource Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies pays -- of its earnings as a dividend. Ladybug Resource Group pays out -- of its earnings as a dividend.

Medicine Man Technologies quarterly revenues are $43.2M, which are larger than Ladybug Resource Group quarterly revenues of --. Medicine Man Technologies's net income of -$13.9M is higher than Ladybug Resource Group's net income of --. Notably, Medicine Man Technologies's price-to-earnings ratio is -- while Ladybug Resource Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies is 0.01x versus -- for Ladybug Resource Group. Usually stocks with elevated PS ratios are considered overvalued.

Nowtransit has a net margin of -32.23% compared to Medicine Man Technologies's net margin of 9.81%. Medicine Man Technologies's return on equity of -39.36% beat Nowtransit's return on equity of 28.6%.

Medicine Man Technologies has a consensus price target of --, signalling upside risk potential of 13101.65%. On the other hand Nowtransit has an analysts' consensus of -- which suggests that it could fall by --. Given that Medicine Man Technologies has higher upside potential than Nowtransit, analysts believe Medicine Man Technologies is more attractive than Nowtransit.

Medicine Man Technologies has a beta of 1.838, which suggesting that the stock is 83.805% more volatile than S&P 500. In comparison Nowtransit has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Medicine Man Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nowtransit offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies pays -- of its earnings as a dividend. Nowtransit pays out -- of its earnings as a dividend.

Medicine Man Technologies quarterly revenues are $43.2M, which are larger than Nowtransit quarterly revenues of $573K. Medicine Man Technologies's net income of -$13.9M is lower than Nowtransit's net income of $56.2K. Notably, Medicine Man Technologies's price-to-earnings ratio is -- while Nowtransit's PE ratio is 7,107.71x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies is 0.01x versus 350.40x for Nowtransit. Usually stocks with elevated PS ratios are considered overvalued.

SunLink Health Systems has a net margin of -32.23% compared to Medicine Man Technologies's net margin of -6.93%. Medicine Man Technologies's return on equity of -39.36% beat SunLink Health Systems's return on equity of -5.08%.

Medicine Man Technologies has a consensus price target of --, signalling upside risk potential of 13101.65%. On the other hand SunLink Health Systems has an analysts' consensus of -- which suggests that it could fall by --. Given that Medicine Man Technologies has higher upside potential than SunLink Health Systems, analysts believe Medicine Man Technologies is more attractive than SunLink Health Systems.

Medicine Man Technologies has a beta of 1.838, which suggesting that the stock is 83.805% more volatile than S&P 500. In comparison SunLink Health Systems has a beta of 1.404, suggesting its more volatile than the S&P 500 by 40.425%.

Medicine Man Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SunLink Health Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medicine Man Technologies pays -- of its earnings as a dividend. SunLink Health Systems pays out -- of its earnings as a dividend.

Medicine Man Technologies quarterly revenues are $43.2M, which are larger than SunLink Health Systems quarterly revenues of $7.9M. Medicine Man Technologies's net income of -$13.9M is lower than SunLink Health Systems's net income of -$549K. Notably, Medicine Man Technologies's price-to-earnings ratio is -- while SunLink Health Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies is 0.01x versus 0.17x for SunLink Health Systems. Usually stocks with elevated PS ratios are considered overvalued.

Walgreens Boots Alliance has a net margin of -32.23% compared to Medicine Man Technologies's net margin of 0.95%. Medicine Man Technologies's return on equity of -39.36% beat Walgreens Boots Alliance's return on equity of -24.93%.

Medicine Man Technologies has a consensus price target of --, signalling upside risk potential of 13101.65%. On the other hand Walgreens Boots Alliance has an analysts' consensus of -- which suggests that it could grow by 12.7%. Given that Medicine Man Technologies has higher upside potential than Walgreens Boots Alliance, analysts believe Medicine Man Technologies is more attractive than Walgreens Boots Alliance.

Medicine Man Technologies has a beta of 1.838, which suggesting that the stock is 83.805% more volatile than S&P 500. In comparison Walgreens Boots Alliance has a beta of 0.664, suggesting its less volatile than the S&P 500 by 33.636%.

Medicine Man Technologies has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Walgreens Boots Alliance offers a yield of 10.88% to investors and pays a quarterly dividend of $0.25 per share. Medicine Man Technologies pays -- of its earnings as a dividend. Walgreens Boots Alliance pays out -14.59% of its earnings as a dividend.

Medicine Man Technologies quarterly revenues are $43.2M, which are smaller than Walgreens Boots Alliance quarterly revenues of $36.4B. Medicine Man Technologies's net income of -$13.9M is lower than Walgreens Boots Alliance's net income of $344M. Notably, Medicine Man Technologies's price-to-earnings ratio is -- while Walgreens Boots Alliance's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medicine Man Technologies is 0.01x versus 0.05x for Walgreens Boots Alliance. Usually stocks with elevated PS ratios are considered overvalued.